About the Nasopharyngeal Cancer Session
Nasopharyngeal cancer, a rare form of head and neck cancer, arises in the nasopharynx, the upper part of the throat behind the nose. Research in this field focuses on understanding the disease's molecular mechanisms, risk factors, and improving treatment outcomes. Key areas of investigation include exploring the role of Epstein-Barr virus (EBV) infection, genetic predisposition, and environmental factors such as diet and tobacco use in cancer development. Innovative therapies such as immunotherapy and targeted molecular treatments are being studied to enhance treatment efficacy and reduce side effects. Early detection methods, including advanced imaging techniques and biomarker identification, are also under scrutiny to improve prognosis and survival rates. Collaborative efforts between clinicians, researchers, and pharmaceutical companies drive progress in combating this challenging cancer type.
Topics Covered in Nasopharyngeal Cancer
EBV-Driven Pathogenesis
Plasma EBV DNA
Nonkeratinizing Carcinoma
Dietary Nitrosamines
Precision Radiotherapy
Checkpoint Inhibitors
Related Scientific Sessions at CIOC 2027
Why Attend the Nasopharyngeal Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Nasopharyngeal Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Nasopharyngeal Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Nasopharyngeal Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Nasopharyngeal Cancer Conference 2027 — FAQs
What is the Nasopharyngeal Cancer track at CIOC 2027?
The Nasopharyngeal Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Nasopharyngeal Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Nasopharyngeal Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Nasopharyngeal Cancer are all welcome — whether presenting or attending.
Can I present my research in the Nasopharyngeal Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Nasopharyngeal Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Nasopharyngeal Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.